Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03408730 · ClinicalTrials.gov registry record · Phase 3
Lot-to-lot Consistency of Sci-B-Vac™ in Adults
A Phase 3 study, sponsored by VBI Vaccines.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,838
- Enrollment target
NCT03408730 is a Phase 3 study that has completed, run by VBI Vaccines. The registered enrollment target is 2,838 participants.
The verdict
NCT03408730, a Phase 3 study, has completed, sponsored by VBI Vaccines.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,838 participants
- Enrollment target
Study Summary
A Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults
Interventions
- BIOLOGICAL Hepatitis B Vaccination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,838 participants |
| Start Date | 2017-12-14 |
| Est. Completion | 2019-10-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03408730
The ClinicalTrials.gov registry entry for NCT03408730 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,838 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VBI Vaccines, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hepatitis B Vaccination is the first listed.
NCT03408730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03408730 about?
NCT03408730 is a clinical study titled "Lot-to-lot Consistency of Sci-B-Vac™ in Adults". A Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults
What is the current status of trial NCT03408730?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,838 participants. The study started on 2017-12-14. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT03408730?
The interventions under investigation include: Hepatitis B Vaccination (BIOLOGICAL).
Who is sponsoring clinical trial NCT03408730?
This trial is sponsored by VBI Vaccines, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.